Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia

PACE - Pacing and Clinical Electrophysiology

Volumn 37, Issue 3, 2014, Pages 364-374

  Nery, Pablo B ^a   Mc Ardle, Brian A ^a   Redpath, Calum J ^a   Leung, Eugene ^b   Lemery, Robert ^a   Dekemp, Robert ^a   Yang, Jim ^a   Keren, Arieh ^a   Beanlands, Rob S ^a   Birnie, David H ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

atrioventricular block; cardiac sarcoidosis; FDG PET; ventricular tachycardia

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PREDNISONE;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; CLINICAL TRIAL; DISEASE SEVERITY; FEMALE; HEART MUSCLE BIOPSY; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOMORPHIC VENTRICULAR TACHYCARDIA; MYOCARDITIS; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; SARCOIDOSIS; YOUNG ADULT;

ATRIOVENTRICULAR BLOCK; CARDIAC SARCOIDOSIS; FDG PET; VENTRICULAR TACHYCARDIA;

CARDIOMYOPATHIES; CAUSALITY; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; ONTARIO; PREVALENCE; RISK ASSESSMENT; SARCOIDOSIS; TACHYCARDIA, VENTRICULAR;

EID: 84895519027     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12277     Document Type: Article

References (32)

1. McGrath DS, Goh N, Foley PJ, du Bois RM,. Sarcoidosis: Genes and microbes-Soil or seed ? Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 149-164.
2. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee. Am J Respir Crit Care Med 1999; 160: 736-755.
3. Sato H, Woodhead FA, Ahmad T, Grutters JC, Spagnolo P, van den Bosch JM, Meier JM, et al. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet 2010; 19: 4100-4111.
4. Youssef G, Beanlands RS, Birnie DH, Nery PB,. Cardiac sarcoidosis: Applications of imaging in diagnosis and directing treatment. Heart 2011; 97: 2078-2087.
5. Ayyala US, Nair AP, Padilla ML,. Cardiac sarcoidosis. Clin Chest Med 2008; 29: 493-508, ix.
6. Dubrey SW, Falk RH,. Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis 2010; 52: 336-346.
7. Boglioli LR, Taff ML, Funke S, Mihalakis I,. Sudden death due to sarcoid heart disease. J Forensic Sci 1998; 43: 1072-1073.
8. Kavanagh T, Huang S,. Cardiac sarcoidosis: An unforeseen cause of sudden death. Can J Cardiol 1995; 11: 136-138.
9. Uusimaa P, Ylitalo K, Anttonen O, Kerola T, Virtanen V, Paakko E, Raatikainen P,. Ventricular tachyarrhythmia as a primary presentation of sarcoidosis. Europace 2008; 10: 760-766.
10. Veinot JP, Johnston B,. Cardiac sarcoidosis-An occult cause of sudden death: A case report and literature review. J Forensic Sci 1998; 43: 715-717.
11. Virmani R, Roberts WC,. Sudden cardiac death. Hum Pathol 1987; 18: 485-492.
12. Nery PB, Leung E, Birnie DH,. Arrhythmias in cardiac sarcoidosis: Diagnosis and treatment. Curr Opin Cardiol 2012; 27: 181-189.
13. Kandolin R, Lehtonen J, Kupari M,. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol 2011; 4: 303-309.
14. Roberts WC, McAllister HA Jr., Ferrans VJ,. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977; 63: 86-108.
15. Kim JS, Judson MA, Donnino R, Gold M, Cooper LT Jr., Prystowsky EN, Prystowsky S,. Cardiac sarcoidosis. Am Heart J 2009; 157: 9-21.
16. Sekiguchi M, Numao Y, Imai M, Furuie T, Mikami R,. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis. Jpn Circ J 1980; 44: 249-263.
17. Soejima K, Yada H,. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: With emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol 2009; 20: 578-583.
18. Klein R, Renaud JM, Ziadi MC, Thorn SL, Adler A, Beanlands RS, de Kemp RA,. Intra- and inter-operator repeatability of myocardial blood flow and myocardial flow reserve measurements using rubidium-82 pet and a highly automated analysis program. J Nucl Cardiol 2010; 17: 600-616.
19. Jefic D, Joel B, Good E, Morady F, Rosman H, Knight B, et al. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: Report from a multicenter registry. Heart Rhythm 2009; 6: 189-195.
20. Thachil A, Christopher J, Sastry BK, Reddy KN, Tourani VK, Hassan A, Raju BS, et al. Monomorphic ventricular tachycardia and mediastinal adenopathy due to granulomatous infiltration in patients with preserved ventricular function. J Am Coll Cardiol 2011; 58: 48-55.
21. Grutters JC, van den Bosch JM,. Corticosteroid treatment in sarcoidosis. Eur Respir J 2006; 28: 627-636.
22. Chiu CZ, Nakatani S, Zhang G, Tachibana T, Ohmori F, Yamagishi M, Kitakaze M, et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 2005; 95: 143-146.
23. Fujita N, Hiroe M, Suzuki Y, Sato H, Inoue Y, Sekiguchi M, Hosoda S, et al. A case with cardiac sarcoidosis. Significance of the effect of steroids on the reversion of advanced atrioventricular block and myocardial scintigraphic abnormalities. Heart Vessels Suppl 1990; 5: 16-18.
24. Kato Y, Morimoto S, Uemura A, Hiramitsu S, Ito T, Hishida H,. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 133-137.
25. Lorell B, Alderman EL, Mason JW,. Cardiac sarcoidosis. Diagnosis with endomyocardial biopsy and treatment with corticosteroids. Am J Cardiol 1978; 42: 143-146.
26. Valantine HA, Tazelaar HD, Macoviak J, Mullin AV, Hunt SA, Fowler MB, Billingham ME,. Cardiac sarcoidosis: Response to steroids and transplantation. J Heart Transplant 1987; 6: 244-250.
27. Banba K, Kusano KF, Nakamura K, Morita H, Ogawa A, Ohtsuka F, Ogo KO, et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm 2007; 4: 1292-1299.
28. Sadek M, Yung D, Birnie D, Nery PB,. Corticosteroid therapy for cardiac sarcoidosis: A systematic review. Can J Cardiol 2013; 28: 1034-1041.
29. Cooper LT Jr., Blauwet LA,. When should high-grade heart block trigger a search for a treatable cardiomyopathy ? Circ Arrhythm Electrophysiol 2011; 4: 260-261.
30. Rahmi A, Deshayes E, Maucort-Boulch D, Varron L, Grange JD, Kodjikian L, Seve P,. Intraocular sarcoidosis: Association of clinical characteristics of uveitis with findings from 18F-labelled fluorodeoxyglucose positron emission tomography. Br J Ophthalmol 2012; 96: 99-103.
31. Herbort CP, Rao NA, Mochizuki M,. International criteria for the diagnosis of ocular sarcoidosis: Results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm 2009; 17: 160-169.
32. Kaiser PK, Lowder CY, Sullivan P, Sanislo SR, Kosmorsky GS, Meziane MA, Rice TW, et al. Chest computerized tomography in the evaluation of uveitis in elderly women. Am J Ophthalmol 2002; 133: 499-505.